<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Metab</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Metab</journal-id><journal-title-group><journal-title>Cancer &#x00026; Metabolism</journal-title></journal-title-group><issn pub-type="epub">2049-3002</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4073004</article-id><article-id pub-id-type="publisher-id">2049-3002-2-S1-P75</article-id><article-id pub-id-type="doi">10.1186/2049-3002-2-S1-P75</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate and promotes histone methylation</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Fan</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="A2"><name><surname>Teng</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Liu</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Looper</surname><given-names>Ryan</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Rabinowitz</surname><given-names>Joshua</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref></contrib></contrib-group><aff id="I1"><label>1</label>Lewis-Sigler Institute for Integrative Genomics and Department of Chemistry, Princeton University, Princeton, NJ, USA</aff><aff id="I2"><label>2</label>Department of Chemistry, University of Utah, Salt Lake City, UT, USA</aff><aff id="I3"><label>3</label>Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>28</day><month>5</month><year>2014</year></pub-date><volume>2</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Metabolism, Diet and Disease 2014: Cancer and metabolism</named-content><named-content content-type="supplement-sponsor">This supplement has not been supported by sponsorship.</named-content></supplement><fpage>P75</fpage><lpage>P75</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Fan et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Fan et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerandmetabolism.com/content/2/S1/P75"/><conference><conf-date>28-30 May 2014</conf-date><conf-name>Metabolism, Diet and Disease 2014: Cancer and metabolism</conf-name><conf-loc>Washington DC, USA</conf-loc></conference></article-meta></front><body><sec><title>Background</title><p>Human phosphoglycerate dehydrogenase (PHGDH), the first enzyme in the serine biosynthetic pathway, is genomically amplified in various tumors [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. In such cells, PHGDH knockdown is not fully rescued by exogenous serine [<xref ref-type="bibr" rid="B2">2</xref>], suggesting possible additional roles for the enzyme.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>To analyze the catalytic activity of PHGDH on possible alternative substrates, we conducted <italic>in vitro</italic> biochemical assays on recombinant human PHGDH. The reaction rate in the reductive direction with various substrates was monitored based on NADH consumption, measured by absorbance at 340 nm. The identity and chirality of products were analyzed by liquid chromatography-mass spectrometry (LC-MS) and by gas chromatography-mass spectrometry (GC-MS) after (R)-2-butanol derivatization. To analyze the intracellular function of PHGDH, we generated stable PHGDH knockdown cell lines, using two shRNA sequences. Metabolite levels in the knockdown cells were analyzed by LC-MS [<xref ref-type="bibr" rid="B4">4</xref>], and DNA and histone methylation was analyzed by immunoblotting.</p></sec><sec sec-type="results"><title>Results</title><p>Here we show that, in addition to catalyzing oxidation of 3-phosphoglycerate, PHGDH catalyzes NADH-dependent reduction of &#x003b1;-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (D-2HG) and promotes histone methylation. The impact of PHGDH knockdown was studied in three cell lines with amplified PHGDH: MDA-MB-468, BT-20, and HCC70. Knockdown of PHGDH decreased 2HG levels in MDA-MB-468 and BT-20 cells, but not HCC70 cells (which had the highest 2HG levels of the three tested cell lines, with levels in MDA-MB-468 and BT-20 cells far below those found in cells with mutant IDH). These results suggest that PHGDH contributes to physiological 2HG pools, but may not produce high enough concentrations to cause pathology. Interestingly, in all three cell lines, PHGDH knockdown substantially decreased histone methylation. The mechanism underlying the decreased methylation upon PHGDH knockdown remains unclear, but it could be restored in MDA-MB-468 and BT-20 cells by addition of D-2HG ester.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>PHGDH may promote histone methylation by mechanisms including 2-HG production.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Mullarky</surname><given-names>E</given-names></name><name><surname>Mattaini</surname><given-names>KR</given-names></name><name><surname>Vander Heiden</surname><given-names>MG</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Locasale</surname><given-names>JW</given-names></name><article-title>PHGDH amplification and altered glucose metabolism in human melanoma</article-title><source>Pigment Cell Melanoma Res</source><year>2011</year><volume>24</volume><fpage>1112</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1111/j.1755-148X.2011.00919.x</pub-id><pub-id pub-id-type="pmid">21981974</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Possemato</surname><given-names>R</given-names></name><etal/><article-title>Functional genomics reveal that the serine synthesis pathway is essential in breast cancer</article-title><source>Nature</source><year>2011</year><volume>476</volume><fpage>346</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1038/nature10350</pub-id><pub-id pub-id-type="pmid">21760589</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Locasale</surname><given-names>JW</given-names></name><etal/><article-title>Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis</article-title><source>Nat Genet</source><year>2011</year><volume>43</volume><fpage>869</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1038/ng.890</pub-id><pub-id pub-id-type="pmid">21804546</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>W</given-names></name><etal/><article-title>Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer</article-title><source>Anal Chem</source><year>2010</year><volume>82</volume><fpage>3212</fpage><lpage>3221</lpage><pub-id pub-id-type="doi">10.1021/ac902837x</pub-id><pub-id pub-id-type="pmid">20349993</pub-id></mixed-citation></ref></ref-list></back></article>